person

Luca A.

Country
Italy
Department
Hematology Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
247
Sites with multiple studies

Has run more than one trial at 247 of 435 partner sites.

Specializations

Lymphoma Specialization

This investigator demonstrates extensive expertise in treating various forms of B-cell lymphomas and T-cell lymphomas, with particular focus on innovative therapeutic approaches.

  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Mantle Cell Lymphoma
  • Follicular Lymphoma
  • Peripheral T-Cell Lymphoma
  • Marginal Zone Lymphoma

Treatment Approaches

The investigator specializes in developing and evaluating novel therapeutic combinations incorporating immunotherapy, targeted therapies, and conventional chemotherapy.

  • Antibody-Based Therapies
  • BTK Inhibitors
  • Immunomodulatory Agents
  • Novel Drug Combinations

Patient Populations

The investigator focuses on treating both newly diagnosed and relapsed/refractory lymphoma patients, with particular attention to specific demographic groups.

  • Previously Untreated Patients
  • Relapsed/Refractory Cases
  • Elderly Patients
  • High-Risk Populations

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.